Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies
Health Canada, a federal department responsible for helping Canadians maintain and improve their health, issued a letter to health care professionals in June, warning them about the risk of congenital anomalies when modafinil is used during pregnancy. Modafinil is indicated to improve wakefulness in [...]
The FDA has issued a safety alert warning that serious breathing difficulties may occur in patients with respiratory risk factors who are using gabapentin (Neurontin, Gralise, Horizant) or pregabalin (Lyrica, Lyrica CR). These risk factors include the use of opioid pain medicines and other [...]
Today the U.S. Food and Drug Administration (FDA) issued a notice requesting nominations for voting members to serve on the Medical Devices Advisory Committee (MDAC) device panels in the Center for Devices and Radiological Health. The MDAC reviews and evaluates data on the safety [...]
According to a safety announcement and consumer update issued April 30, the U.S. Food and Drug Administration is requiring the addition of a boxed warning to the prescribing information and the patient medication guides for the insomnia medications eszopiclone (Lunesta), zaleplon (Sonata), and zolpidem [...]
The U.S. Food and Drug Administration today announced the approval of a new treatment option for patients who have been diagnosed with moderate to severe central sleep apnea. The Remedē System is an implantable device that stimulates a nerve located in the chest that [...]